ADHD and Tics — MRCPsych Paper B MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Assess causality and impact, then reduce the dose or switch medication if the tics are stimulant-related
The correct answer is C. NICE advises first considering whether the tics are genuinely related to the stimulant, because tics naturally wax and wane, and whether tic-related impairment outweighs the benefits of ADHD treatment. If the tics are stimulant-related, management may include reducing the stimulant dose or changing to guanfacine, atomoxetine or, with appropriate specialist advice, clonidine; stopping medication is another option. Immediate discontinuation is therefore not routinely required. Continuing unchanged may sometimes follow an individual risk–benefit assessment, but it is not justified merely by assuming that all tics are self-limiting. Tics can occur or worsen during stimulant treatment, so option A is incorrect. Adding haloperidol without first assessing causality, severity and treatment benefit is not the NICE-recommended initial approach.
Reference: National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management (NG87), sections 1.8.13–1.8.14, 2018 (reviewed 2025). https://www.nice.org.uk/guidance/ng87/chapter/recommendations